axiebet88 legit or not

In addition to the Firework Easter Eggs, the "Black Myth: Wukong" Lunar New Year set for the female protagonist also introduces new cosmetic items and abilities that further enhance the gameplay experience. Players can customize their character with traditional Lunar New Year outfits, accessories, and hairstyles, adding a touch of authenticity and flair to their in-game avatar. The new abilities unlocked with the set allow players to unleash powerful attacks and maneuvers, making them feel more connected to their character and immersed in the game world.The Shanghai Composite Index, the Shenzhen Component Index, and the ChiNext Index all experienced a collective surge at the opening bell. This positive momentum sent a wave of optimism throughout the market, as traders and investors alike scrambled to capitalize on the newfound bullish sentiment.

In addition to the event, exclusive merchandise and limited-edition collectibles will be available for purchase, allowing fans to take home a piece of the Sonic universe to treasure forever. Whether you're a longtime fan or new to the world of Sonic, there will be something special for everyone to discover at this unforgettable event.Scots will save as little as 1p a day after income tax changes as millions face huge council rate hikes

Title: "6 First-Prize Winners in Grand Lotto! Fortunes Shine on Six Cities with Over 56.22 Million in Total Prize Money"

Venlo, the Netherlands, Nov. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal and viral targets. These new tools enable researchers to customize their assays and panels for use on the QIAcuity digital PCR system as well as on any third-party next-generation sequencing (NGS) system. They also build on more than 700 digital PCR assays that are currently available for microbial targets through the GeneGlobe platform at https://geneglobe.qiagen.com . The new products make nanoplate digital PCR (dPCR) suitable for even more microbial targets in applications ranging from wastewater testing to food production to analysis of human pathogens. With nanoplate dPCR, rare targets in low-biomass samples with high levels of PCR inhibitors can be measured without a standard curve and with high accuracy and precision. “The demands for microbial detection, tracking and scientific research can be extremely specialized. Reliable and accurate tools that can be customized give scientists the flexibility they need to outpace pathogens and accelerate the tempo of discovery,” said Nitin Sood, Senior Vice President and head of QIAGEN’s Life Sciences Business Area. “With the launch of our design tool for Custom dPCR Microbial Assays and the new QIAseq xHXB panels, we are addressing the demands of our customers. QIAGEN will continue to expand our offering of accurate, reliable and easy-to-use solutions.” The new tools are: Design tool for Custom dPCR Microbial Assays – The first-of-its-kind custom assay design tool enables users to design primers and probes for their specific microbial targets of interest and is tailored specifically for bacterial, fungal and viral targets. The design tool software is powered by a sophisticated and thoroughly tested algorithm developed specifically for microbial applications. Researchers can benefit from a user-friendly and intuitive tool that helps them quickly obtain custom assays with optimal sensitivity, specificity and accurate off-target prediction. QIAseq xHYB Custom Microbial Panels – Customers can completely design their own NGS panels, overcoming limitations of panels offered by other vendors, which are designed against a few genomes of a given target and thereby often cause large gaps in coverage. The QIAseq xHYB Custom Microbial Panels advanced algorithm enables researchers to design their assays against many whole genomes at once, allowing them to achieve the highest possible resolution in applications such as microbial detection. QIAGEN continues to expand its portfolio dPCR assays, supporting laboratories to increase their detection capabilities and improve their results. In September, the company added over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications. These newly launched cancer and microbial assays meet the level of quality, multiplexing capabilities, customization, precision and sensitivity associated with all QIAcuity products. Customizable digital PCR assays and the customizable panels and assays are now available on QIAGEN’s GeneGlobe web portal ( https://geneglobe.qiagen.com ), which integrates pre-designed assays with a database of more than 10,000 biological entities including genes, miRNAs and pathways. About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of September 30, 2024, QIAGEN employed more than 5,800 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com . Forward-Looking Statement Certain statements contained in this press release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN's products, timing for launch and development, marketing and/or regulatory approvals, financial and operational outlook, growth and expansion, collaborations, markets, strategy or operating results, including without limitation its expected adjusted net sales and adjusted diluted earnings results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations, regulatory processes and dependence on logistics), variability of operating results and allocations between customer classes, the commercial development of markets for our products to customers in academia, pharma, applied testing and molecular diagnostics; changing relationships with customers, suppliers and strategic partners; competition; rapid or unexpected changes in technologies; fluctuations in demand for QIAGEN's products (including fluctuations due to general economic conditions, the level and timing of customers' funding, budgets and other factors); our ability to obtain regulatory approval of our products; difficulties in successfully adapting QIAGEN's products to integrated solutions and producing such products; the ability of QIAGEN to identify and develop new products and to differentiate and protect our products from competitors' products; market acceptance of QIAGEN's new products and the integration of acquired technologies and businesses; actions of governments, global or regional economic developments, weather or transportation delays, natural disasters, political or public health crises, and its impact on the demand for our products and other aspects of our business, or other force majeure events; as well as the possibility that expected benefits related to recent or pending acquisitions may not materialize as expected; and the other factors discussed under the heading “Risk Factors in our most recent Annual Report on Form 20-F. For further information, please refer to the discussions in reports that QIAGEN has filed with, or furnished to, the U.S. Securities and Exchange Commission. Source: QIAGEN N.V. Category: Corporate

For investors looking to make the most of this upward trend, there are several strategies they can consider. One approach is to identify undervalued stocks with strong growth potential and accumulate them at a lower price point. This can lead to significant returns once the stock prices rise in line with market trends.In conclusion, the accident scene revealed after the man's distracted driving led to the injury of three people serves as a poignant reminder of the importance of maintaining focus and vigilance while behind the wheel. Let us all strive to be responsible and attentive drivers to help prevent such tragedies from occurring in the future.HONG KONG , Nov. 27, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (Nasdaq: ICLK), a renowned online marketing and enterprise solutions provider in Asia that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced unaudited financial results for the six months ended June 30, 2024 . Six Months Ended June 30, 2024 2023 Percentage change (US$ in thousands) (Unaudited) Financial Metrics: Revenue from continuing operations Marketing Solutions 9,324 12,663 (26) % Enterprise Solutions 4,896 4,330 13 % Total revenue from continuing operations 14,220 16,993 (16) % Gross profit from continuing operations 8,096 9,276 (13) % Net loss from continuing operations (1,269) (10,275) N/M Net loss from discontinued operations (5,104) (18,294) N/M Diluted net loss from continuing operations per American Depositary Shares ("ADS") (0.12) (1.01) N/M Operating Metrics: Gross billing 23,060 29,983 (23) % "I am pleased to report that our continuing operations recorded an improvement in gross margin to 56.9% in the first half of 2024 from 54.6% in the first half of 2023, and we saw the increase in enterprise solutions revenue by 13% year-over-year. The Company will continue to focus on improving the financial performance and cash flows, while exploring strategic opportunities for broader business growth.", said Mr. Jian Tang , Chairman, Chief Executive Officer and Co-Founder of iClick. "We continue monitoring and evaluating operations and market trends proactively in order to optimize our business and enhance profitability. We have recently completed the disposal of our mainland China Enterprise Solutions business and demand side Marketing Solutions business. The results of these businesses are presented under discontinued operations." First Half Year of 2024 Results on Continuing Operations: Revenue for the first half of 2024 was US$14.2 million , compared with US$17.0 million for the first half of 2023. Revenue from Marketing Solutions declined to US$9.3 million for the first half of 2024, compared with US$12.7 million for the first half of 2023. It was resulted from our strategic contraction of lower margin and higher risk businesses, with weaker demand from clients on advertising spending due to uncertainty in the macro-economic environment. Revenue from Enterprise Solutions was US$4.9 million for the first half of 2024, improved from US$4.3 million in the first half of 2023 due to the increasing demand for digital transformation and services. Gross profit for the first half of 2024 was US$8.1 million , compared with US$9.3 million for the first half of 2023. With the effort of reducing lower margin and higher risk businesses, and a rising revenue contribution from the higher-margin Enterprise Solutions business, gross profit margin increased to 56.9% for the first half of 2024 from 54.6% for the first half of 2023. Total operating expenses were US$12.4 million for the first half of 2024, decreased from US$14.1 million for the first half of 2023. The change was primarily due to our cost optimization execution, which resulted in reduction of staff cost and savings on promotional expenses. The expected credit losses provision of trade receivables was also reduced because of our close monitoring of cash collection. Net loss from continuing operations was US$1 .3 million for the first half of 2024, significantly improved from the net loss of US$10.3 million for the first half of 2023, mainly due to no impairment of equity investments in the first half of 2024, which we recorded US$5.6 million in the first half of 2023. Operating loss was reduced by US$0.6 million . Net loss from continuing operations attributable to the Company's shareholders per basic and diluted ADS for the first half of 2024 was US$0.12, compared with a net loss attributable to the Company's shareholders per basic and diluted ADS of US$1.01 for the first half of 2023. Gross billing 1 from continuing operations was US$23.1 million for the first half of 2024, compared with US$30.0 million for the first half of 2023, mainly as a result of our continued strategy of reducing lower margin and higher risk businesses, as well as clients' reduced advertising spending. Net loss from discontinued operations was US$5 .1 million for the first half of 2024, compared with the net loss of US$18.3 million for the first half of 2023, mainly due to cost optimization, and gain on disposal of discontinued operations amounting to US$2 .6 million in the first half of 2024. As of June 30, 2024 , the continuing operations of the Company had cash and cash equivalents, time deposits and restricted cash of US$70.2 million , compared with US$41.3 million as of December 31, 2023 . About iClick Interactive Asia Group Limited Founded in 2009, iClick Interactive Asia Group Limited (NASDAQ: ICLK) is a renowned online marketing and enterprise solutions provider in Asia . With its leading proprietary technologies, iClick's full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. For more information, please visit https://ir.i-click.com . 1 Gross billing is defined as the aggregate dollar amount that clients pay the Company after deducting rebates paid and discounts given to. Safe Harbor Statement This announcement contains forward-looking statements, including those related to the Company's business strategies, operations and financial performance. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks and uncertainties. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. For investor and media inquiries, please contact: In China: In the United States: iClick Interactive Asia Group Limited Core IR Catherine Chau Tom Caden Phone: +852 3700 9100 Tel: +1-516-222-2560 E-mail: ir@i-click.com E-mail: tomc@coreir.com (financial tables follow) ICLICK INTERACTIVE ASIA GROUP LIMITED Unaudited Condensed Consolidated Statements of Comprehensive Loss (US$'000, except share data and per share data, or otherwise noted, unaudited) Six Months Ended June 30, 2024 2023 Continuing operations Revenue 14,220 16,993 Cost of revenue (6,124) (7,717) Gross profit 8,096 9,276 Operating expenses Research and development expenses (311) (265) Sales and marketing expenses (4,381) (8,826) General and administrative expenses (7,704) (5,052) Total operating expenses (12,396) (14,143) Interest expense (32) (117) Interest income 598 591 Other gains/(losses), net 2,560 (5,756) Loss before income tax expense and share of losses from an equity investee (1,174) (10,149) Share of losses from an equity investee (37) (19) Loss before income tax expense (1,211) (10,168) Income tax expense (58) (107) Net loss from continuing operations (1,269) (10,275) Net loss attributable to non-controlling interests 111 9 Net loss from continuing operations attributable to iClick Interactive Asia Group Limited's ordinary shareholders (1,158) (10,266) Discontinued operations Loss from operations of discontinued operations (7,666) (18,305) Income tax (expense)/credit (23) 11 Gain on disposal of discontinued operations 2,585 - Net loss from discontinued operations (5,104) (18,294) Net loss attributable to non-controlling interests 32 49 Net loss from discontinued operations attributable to iClick Interactive Asia Group Limited's ordinary shareholders (5,072) (18,245) Net loss (6,373) (28,569) Net loss attributable to iClick Interactive Asia Group Limited's ordinary shareholders (6,230) (28,511) Net loss from continuing operations (1,269) (10,275) Other comprehensive loss: Foreign currency translation adjustment, net of US$nil tax (13) (131) Comprehensive loss from continuing operations (1,282) (10,406) Comprehensive loss from continuing operations attributable to non-controlling interests 111 49 Comprehensive loss from continuing operations attributable to iClick Interactive Asia Group Limited's ordinary shareholders (1,171) (10,357) Net loss from discontinued operations (5,104) (18,294) Other comprehensive income: Foreign currency translation adjustment, net of US$nil tax - 301 Comprehensive loss from discontinued operations (5,104) (17,993) Comprehensive loss from discontinued operations attributable to non -controlling interests 32 20 Comprehensive loss from discontinued operations attributable to iClick Interactive Asia Group Limited's ordinary shareholders (5,072) (17,973) Comprehensive loss attributable to iClick Interactive Asia Group Limited's ordinary shareholders (6,243) (28,330) Net loss from continuing operations per ADS attributable to iClick Interactive Asia Group Limited's ordinary shareholders — Basic (0.12) (1.01) — Diluted (0.12) (1.01) Net loss from discontinued operations per ADS attributable to iClick Interactive Asia Group Limited's ordinary shareholders — Basic (0.51) (1.79) — Diluted (0.51) (1.79) Net loss per ADS attributable to iClick Interactive Asia Group Limited's ordinary shareholders — Basic (0.63) (2.80) — Diluted (0.63) (2.80) Weighted average number of ADS used in per share calculation: — Basic 9,955,943 10,178,966 — Diluted 9,955,943 10,178,966 ICLICK INTERACTIVE ASIA GROUP LIMITED Unaudited Condensed Consolidated Balance Sheets (US$'000, except share data and per share data, or otherwise noted, unaudited) As of June 30, 2024 As of December 31, 2023 Assets Current assets Cash and cash equivalents, time deposits and restricted cash 70,239 41,264 Accounts receivable, net of allowance for credit losses of US$1,558 and US$1,571 as of June 30, 2024 and December 31, 2023 respectively 11,210 13,535 Other current assets 15,813 11,516 Discontinued operations 54,454 93,488 Total current assets 151,716 159,803 Non-current assets Other assets 3,727 3,596 Discontinued operations 112 305 Total non-current assets 3,839 3,901 Total assets 155,555 163,704 Liabilities and equity Current liabilities Accounts payable 3,310 4,462 Bank borrowings 36,932 1,965 Other current liabilities 23,830 20,200 Discontinued operations 56,607 93,445 Total current liabilities 120,679 120,072 Non-current liabilities Other liabilities 221 551 Discontinued operations 1,463 1,829 Total non-current liabilities 1,684 2,380 Total liabilities 122,363 122,452 Equity Ordinary shares – Class A (US$0.001 par value; 80,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 38,752,446 shares and 44,477,356 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively) 39 45 Ordinary shares – Class B (US$0.001 par value; 20,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 5,034,427 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively) 5 5 Treasury shares (218,396 shares and 6,398,616 shares as of June 30, 2024 and December 31, 2023, respectively)

Hochul asks Biden admin. for more border resourcesITV I'm A Celebrity viewers issue 'predictable' complaint as winner of 2024 series announced

But opening a window isn't just about letting in physical light and air – it's also about opening ourselves up to new perspectives and possibilities. When we step out of our comfort zones and embrace change, we invite growth and transformation into our lives. We become more receptive to new ideas, more attuned to the world around us, and more connected to our true selves.

On the other hand, Jokic himself has expressed his admiration for his teammates' performances and downplayed the significance of his individual scoring outburst. He emphasized that basketball is a team sport and that his success on the court is a result of collective effort and teamwork.